FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Bill Would Create FDA Office of Mobile Health

[ Price : $8.95]

Rep. Mike Honda says he will introduce a bill to create an Office of Mobile Health in FDA.

Vantas Caregiver Brochure Omits Risk Informatio: OPDP

[ Price : $8.95]

CDERs Office of Prescription Drug Promotion says that an Endo caregiver brochure downplays significant risks associated with Vanta...

Boehringer Ends Phase 3 Study Enrollment for Pulmonary Fibrosis Drug

[ Price : $8.95]

Boehringer Ingelheim completes enrollment of 970 patients in two Phase 3 clinical trials evaluating the safety and efficacy of nin...

FDA Clears Bolton Medical Relay Stent Graft

[ Price : $8.95]

FDA clears a Bolton Medical Relay thoracic aorta stent.

Depomed Sues FDA Over Gralise Non-Orphan Exclusivity

[ Price : $8.95]

Depomed sues FDA over the agencys refusal to grant Orphan Drug exclusivity to its drug, Gralise (gabapentin), and its use in manag...

FDAs Skin Wash Designation Arbitrary and Capricious: Court

[ Price : $8.95]

DC federal court judge Rosemary Collyer faults FDA for its determination that Prevors skin wash product is a combination product w...

Advisors Asked if Retinal Prosthesis is Safe, Effective

[ Price : $8.95]

FDA asks members of its Ophthalmic Devices Panel whether a retinal prosthesis is likely to be safe and effective in inducing visua...

FDA Approves REMS for Mycophenolate Drugs

[ Price : $8.95]

FDA approves a REMS including a pregnancy registry for all mycophenolate-containing drugs.

Device-related Key Issues Under FDASIA: Blog

[ Price : $8.95]

A Hyman Phelps & McNamara blog posting summarizes key provisions CDRH is working on after the passage of the FDA Safety and Innova...

Pfizer Wants Generic Oxecta ANDA Restrictions

[ Price : $8.95]

Pfizer asks FDA to require applicants for generic Oxecta to use the same inactive ingredients that contribute to its safety profil...